Therapeutic targets modulation, inhibition, and activation /
I tiakina i:
Kaituhi rangatōpū: | ebrary, Inc |
---|---|
Ētahi atu kaituhi: | Botana, Luis M., Loza, Mabel |
Hōputu: | Tāhiko īPukapuka |
Reo: | Ingarihi |
I whakaputaina: |
Hoboken, N.J. :
John Wiley & Sons,
c2012.
|
Ngā marau: | |
Urunga tuihono: | An electronic book accessible through the World Wide Web; click to view |
Ngā Tūtohu: |
Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
Ngā tūemi rite
ADME-enabling technologies for drug design and development
I whakaputaina: (2012)
I whakaputaina: (2012)
Development of therapeutic agents handbook
I whakaputaina: (2012)
I whakaputaina: (2012)
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
mā: Rosenberg, Michael J.
I whakaputaina: (2010)
Pharmaceutical industry innovation and developments /
I whakaputaina: (2011)
I whakaputaina: (2011)
Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)
I whakaputaina: (2006)
Quality assurance of pharmaceuticals a compendium of guidelines and related materials. Volume 2, Good manufacturing practices and inspection.
I whakaputaina: (2007)
I whakaputaina: (2007)
Drugs : from discovery to approval /
mā: Ng, Rick
I whakaputaina: (2015)
mā: Ng, Rick
I whakaputaina: (2015)
Gene family targeted molecular design
I whakaputaina: (2009)
I whakaputaina: (2009)
Drug discovery and design medical aspects /
I whakaputaina: (2002)
I whakaputaina: (2002)
Drug discovery practices, processes, and perspectives /
I whakaputaina: (2013)
I whakaputaina: (2013)
Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
I whakaputaina: (2012)
I whakaputaina: (2012)
Applications of microdialysis in pharmaceutical science
I whakaputaina: (2011)
I whakaputaina: (2011)
Drug discovery handbook
I whakaputaina: (2005)
I whakaputaina: (2005)
Retrometabolic drug design and targeting
mā: Bodor, Nicholas
I whakaputaina: (2012)
mā: Bodor, Nicholas
I whakaputaina: (2012)
Human drug targets : a compendium for pharmaceutical discovery /
mā: Zanders, Edward D.
I whakaputaina: (2016)
mā: Zanders, Edward D.
I whakaputaina: (2016)
Target validation in drug discovery
I whakaputaina: (2006)
I whakaputaina: (2006)
Statistical thinking for non-statisticians in drug regulation /
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
mā: Kay, R. (Richard), 1949-
I whakaputaina: (2015)
Post-genomic approaches in drug and vaccine development /
I whakaputaina: (2015)
I whakaputaina: (2015)
Pharmacokinetics and metabolism in drug design
I whakaputaina: (2012)
I whakaputaina: (2012)
Pharmacogenetics opportunities and challenges for health innovation.
I whakaputaina: (2009)
I whakaputaina: (2009)
The quest for the cures the science, stories and struggles behind the next generation of medicines /
mā: Stockwell, Brent R.
I whakaputaina: (2011)
mā: Stockwell, Brent R.
I whakaputaina: (2011)
Peptide chemistry and drug design /
I whakaputaina: (2015)
I whakaputaina: (2015)
Lead generation approaches in drug discovery
I whakaputaina: (2010)
I whakaputaina: (2010)
Physicochemical and biomimetic properties in drug discovery : chromatographic techniques for lead optimization /
mā: Valkó, Klára
I whakaputaina: (2014)
mā: Valkó, Klára
I whakaputaina: (2014)
A mathematical approach to multilevel, multiscale health interventions pharmaceutical industry decline and policy response /
mā: Wallace, Rodrick
I whakaputaina: (2013)
mā: Wallace, Rodrick
I whakaputaina: (2013)
Recent advances
I whakaputaina: (2002)
I whakaputaina: (2002)
3D QSAR in drug design
I whakaputaina: (2002)
I whakaputaina: (2002)
Virtual ADMET assessment in target selection and maturation
I whakaputaina: (2006)
I whakaputaina: (2006)
The textbook of pharmaceutical medicine
I whakaputaina: (2002)
I whakaputaina: (2002)
Case studies in modern drug discovery and development
I whakaputaina: (2012)
I whakaputaina: (2012)
Novel frontiers in the production of compounds for biomedical use
I whakaputaina: (2002)
I whakaputaina: (2002)
Modern drug synthesis
I whakaputaina: (2010)
I whakaputaina: (2010)
The art of drug synthesis
I whakaputaina: (2007)
I whakaputaina: (2007)
Frontiers in drug design and discovery.
I whakaputaina: (2010)
I whakaputaina: (2010)
Successful drug discovery.
I whakaputaina: (2015)
I whakaputaina: (2015)
Chemical drug design /
I whakaputaina: (2016)
I whakaputaina: (2016)
Physiologically-based pharmacokinetic (PBPK) modeling and simulations principles, methods, and applications in the pharmaceutical industry /
mā: Peters, Sheila Annie
I whakaputaina: (2011)
mā: Peters, Sheila Annie
I whakaputaina: (2011)
Pharmaceutical blending and mixing /
I whakaputaina: (2015)
I whakaputaina: (2015)
Pharmaceutical pricing policies in a global market
I whakaputaina: (2008)
I whakaputaina: (2008)
Les prix des medicaments sur un marche global politiques et enjeux.
I whakaputaina: (2008)
I whakaputaina: (2008)
Ngā tūemi rite
-
ADME-enabling technologies for drug design and development
I whakaputaina: (2012) -
Development of therapeutic agents handbook
I whakaputaina: (2012) -
The agile approach to adaptive research optimizing efficiency in clinical development /
mā: Rosenberg, Michael J.
I whakaputaina: (2010) -
Pharmaceutical industry innovation and developments /
I whakaputaina: (2011) -
Outsourcing clinical development strategies for working with CROs and other partners /
I whakaputaina: (2006)